Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass

Clinical trial NCT01373216 · COMPLETED

Trial details

NCT number: NCT01373216
Sponsor: Charles University, Czech Republic
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Disease Decreased Left Ventricular Function

Start date: 2011-06-01
Primary completion: 2014-05-01
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.